Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Case

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
American Journal of Physiology. Endocrinology and Metabolism|November 6, 2014
Inhibition of secreted frizzled-related protein 5 improves glucose metabolismIngrid C Rulifson, Jiangwen Z Majeti, Yumei Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2021
Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's diseaseDaniel C Ellwanger, Shoutang Wang, Simone Brioschi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2019
Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine ReleaseChristina L Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Cancer Discovery|October 20, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate CancerOlivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Molecular Cancer Therapeutics|June 11, 2020
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid LeukemiaBettina Brauchle, Rebecca L Goldstein, Christine M Karbowski, et al.
Nature Communications|May 28, 2016
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repairMonica Florio, Kannan Gunasekaran, Marina Stolina, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Physiology. Endocrinology and Metabolism|November 6, 2014
Inhibition of secreted frizzled-related protein 5 improves glucose metabolismIngrid C Rulifson, Jiangwen Z Majeti, Yumei Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2021
Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's diseaseDaniel C Ellwanger, Shoutang Wang, Simone Brioschi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2019
Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine ReleaseChristina L Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Cancer Discovery|October 20, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate CancerOlivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Molecular Cancer Therapeutics|June 11, 2020
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid LeukemiaBettina Brauchle, Rebecca L Goldstein, Christine M Karbowski, et al.
Nature Communications|May 28, 2016
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repairMonica Florio, Kannan Gunasekaran, Marina Stolina, et al.
Pageof 2